Top 31 Surgical Pathologist Interview Questions and Answers [Updated 2025]

In a recent case, I worked closely with a surgical team on a complex tumor. I provided detailed pathology reports that impacted their surgical approach, resulting in better tumor margins. After the surgery, the patient had a faster recovery and fewer complications.

In a recent case, I encountered a complex sarcoma that initially presented as a benign lesion. I reviewed the histological slides multiple times and consulted with a radiologist for imaging correlation. We performed immunohistochemistry which confirmed my suspicion. The result was a tailored treatment plan for the patient and I learned the value of thorough investigation and teamwork.

In my previous role, I mentored a junior pathologist who was struggling with diagnostic skills. I scheduled weekly one-on-one meetings to review difficult cases and provided constructive feedback. By encouraging open communication, they gained confidence and improved their accuracy in diagnoses, which was evident in their subsequent evaluations.

I once presented pathology results to a group of patient advocates. I explained that cancer cells are like weeds in a garden, overtaking the healthy plants. I emphasized the importance of early detection, which is like catching weeds before they spread.

I acknowledge that delivering difficult diagnoses is very challenging. I always aim to communicate in a clear and compassionate manner, allowing space for patients and families to process the information and ask questions. I also make sure to take care of my own emotional health to handle these situations better.

During a routine review of biopsy samples, I noticed a subtle but atypical cell morphology that was overlooked in previous assessments. I double-checked the slides and consulted with colleagues, leading to a re-evaluation of the diagnosis. This attention to detail resulted in a correct identification of an early stage cancer, allowing timely intervention and significantly improving the patient’s prognosis.

In my fellowship, a senior pathologist reviewed my tissue staining technique and pointed out inconsistencies in my sectioning. I was initially surprised, but I took a step back and asked for specific examples. I practiced the technique more diligently and sought feedback from colleagues. This improved my accuracy significantly and I learned the importance of attention to detail in lab work.

I ensure my work is patient-centered by carefully considering how my diagnoses will affect the patient's treatment plan. I regularly discuss findings with the clinical team to ensure we are aligned on patient care.

In my previous role, I introduced digital pathology images to improve diagnostic accuracy. I noticed discrepancies in slide interpretations and proposed using a digital system for remote consultations. After implementation, we reduced turnaround times by 25% and increased accuracy, receiving positive feedback from the pathologists.

In a recent case involving a patient with suspected lymphoma, I decided to recommend a follow-up biopsy after initial results were inconclusive. This decision was based on the potential for misdiagnosis and the patient's concerning clinical symptoms. Following the re-biopsy, we confirmed the diagnosis, leading to timely treatment. This significantly improved the patient's prognosis.

I maintain a strict schedule where I allocate after-hours time strictly for personal activities, ensuring that I disconnect from work fully. This allows me to recharge and return to my responsibilities with renewed focus.

I typically use formalin fixation to preserve tissue morphology, followed by embedding in paraffin. I perform microtomy to obtain thin sections and use hematoxylin and eosin staining for initial examination under the microscope.

I have worked with systems like Phillip's IntelliSite and PathAI. These systems streamline workflow, allowing for quicker diagnosis and collaboration with colleagues remotely.

I adhere to standardized protocols for sample handling and ensure that all cases are reviewed by a colleague to confirm findings, which greatly enhances accuracy.

I differentiate lesions by first assessing the cellular architecture and morphology. Malignant lesions often show more pleomorphism and increased mitotic figures compared to benign ones. Contextual patient history also plays a vital role in my evaluations.

Immunohistochemistry is a technique used in surgical pathology to visualize specific antigens in tissue sections. The process involves preparing the tissue, applying antibodies that bind to target proteins, and using a visualization method to see the results. It is crucial for diagnosing various cancers, as it helps differentiate between types based on their molecular characteristics.

I have the most experience in gastrointestinal and dermatopathology. I handled numerous cases of GI tumors during my fellowship, focusing on challenging diagnoses. Additionally, I have published research on melanoma diagnostic criteria.

I subscribe to The American Journal of Surgical Pathology and regularly read new issues to keep up with advancements. Also, I attend the annual USCAP meeting, which provides a great opportunity to learn directly from leaders in the field.

I begin by collecting the tissue specimen, ensuring proper labeling and documentation. I use formalin for fixation to preserve the morphology. After fixation, I embed the tissue in paraffin, then cut the sections to 5 micrometers using a microtome. Finally, I perform staining, often using H&E, to distinguish cellular components for microscopic examination.

An effective pathology report should clearly identify the diagnosis, backed up by the findings from the histological examination. Relevant clinical information, such as the patient's history or presenting symptoms, helps contextualize the diagnosis and informs treatment decisions.

I regularly attend pathology conferences and read journals to learn about the latest technologies. For instance, I've started using digital imaging tools to enhance diagnostic accuracy and efficiency.

I would start by reviewing the clinical history in detail and comparing it with the specimen findings. If there are significant discrepancies, I would reach out to the referring physician to clarify the conflicting information. Based on that discussion, I would perform any additional required tests to arrive at a diagnosis that is well-supported by the evidence.

I would first listen to the surgeon's concerns without interrupting, showing that I value their opinion. Then, I would explain my findings and the evidence supporting them. If needed, I would suggest we review the case together to clarify any misunderstandings.

I would first discuss my concerns directly with my colleague, providing specific examples of what I've observed. If the problem persists, I would refer to our reporting protocols and bring it to a supervisor's attention to ensure proper patient care.

I would start by evaluating the clinical urgency of each specimen, prioritizing those that require immediate attention. Then, I would focus on simpler cases first to clear them off my list and create more time for complex specimens.

I would start by analyzing the existing workflows in our department to identify inefficiencies. Then, I would involve my colleagues and pathologists to gather their insights and buy-in for new changes. Together, we would set specific goals to enhance our diagnostic accuracy. I’d implement changes in a pilot phase, collecting data to track improvements. Finally, I would evaluate the outcomes and make necessary adjustments to sustain quality enhancements.

I would arrange regular interdisciplinary meetings to discuss cases, using clear and straightforward language to ensure everyone understands their roles. I would also encourage team members to share their insights openly and listen actively to their suggestions.

If I discovered a significant error in a released report, I would immediately assess its impact on patient care to determine urgency. I would promptly notify my supervisor and the clinicians involved, and correct the report, issuing a revised document. Finally, I would document the incident and participate in a review to prevent future errors.

I would start by gathering more clinical data to ensure I have all relevant information. If still unsure, I would consult with the referring doctor or clinical team to get their insights on the case.

I would first notify the lab supervisor to ensure awareness of the oversight. Then, I would review the specimen's details and request that it be prioritized for processing since it is labeled as critical. I’d also inform the requesting physician about the delay.

I would first meet with each team member individually to understand their perspectives on the conflict. Then, I would bring them together to discuss their differences in a safe environment. Together, we would look for common ground and decide on steps to improve communication and workflow.